132 related articles for article (PubMed ID: 1428914)
1. Ligands and tracers for PET studies of the 5-HT system--current status.
Crouzel C; Guillaume M; Barre L; Lemaire C; Pike VW
Int J Rad Appl Instrum B; 1992 Nov; 19(8):857-70. PubMed ID: 1428914
[TBL] [Abstract][Full Text] [Related]
2. Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them?
Busatto GF
Eur J Nucl Med; 1996 Aug; 23(8):867-70. PubMed ID: 8753673
[No Abstract] [Full Text] [Related]
3. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites--current status.
Pike VW; Halldin C; Crouzel C; Barré L; Nutt DJ; Osman S; Shah F; Turton DR; Waters SL
Nucl Med Biol; 1993 May; 20(4):503-25. PubMed ID: 8389223
[TBL] [Abstract][Full Text] [Related]
4. Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of way.
Pike VW; Halldin C; Wikström H; Marchais S; McCarron JA; Sandell J; Nowicki B; Swahn CG; Osman S; Hume SP; Constantinou M; Andrée B; Farde L
Nucl Med Biol; 2000 Jul; 27(5):449-55. PubMed ID: 10962249
[TBL] [Abstract][Full Text] [Related]
5. A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT(1A) receptor PET radioligands.
Cliffe IA
Nucl Med Biol; 2000 Jul; 27(5):441-7. PubMed ID: 10962248
[TBL] [Abstract][Full Text] [Related]
6. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
[TBL] [Abstract][Full Text] [Related]
7. Radioligands for PET studies of central 5-HT receptors and re-uptake sites--current status.
Pike VW
Nucl Med Biol; 1995 Nov; 22(8):1011-8. PubMed ID: 8998460
[No Abstract] [Full Text] [Related]
8. The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.
Andrée B; Halldin C; Pike VW; Gunn RN; Olsson H; Farde L
J Nucl Med; 2002 Mar; 43(3):292-303. PubMed ID: 11884487
[TBL] [Abstract][Full Text] [Related]
9. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
Blin J; Pappata S; Kiyosawa M; Crouzel C; Baron JC
Eur J Pharmacol; 1988 Feb; 147(1):73-82. PubMed ID: 3259509
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.
Lewis R; Kapur S; Jones C; DaSilva J; Brown GM; Wilson AA; Houle S; Zipursky RB
Am J Psychiatry; 1999 Jan; 156(1):72-8. PubMed ID: 9892300
[TBL] [Abstract][Full Text] [Related]
11. Radioligands for the study of brain 5-HT1A receptors in vivo.
Pike VW; Halldin C; Wikström HV
Prog Med Chem; 2001; 38():189-247. PubMed ID: 11774795
[No Abstract] [Full Text] [Related]
12. [(18)F]p-MPPF: aA radiolabeled antagonist for the study of 5-HT(1A) receptors with PET.
Plenevaux A; Lemaire C; Aerts J; Lacan G; Rubins D; Melega WP; Brihaye C; Degueldre C; Fuchs S; Salmon E; Maquet P; Laureys S; Damhaut P; Weissmann D; Le Bars D; Pujol JF; Luxen A
Nucl Med Biol; 2000 Jul; 27(5):467-71. PubMed ID: 10962252
[TBL] [Abstract][Full Text] [Related]
13. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L
Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260
[TBL] [Abstract][Full Text] [Related]
14. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
[TBL] [Abstract][Full Text] [Related]
15. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
Moulignier A
Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
17. A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humans.
Yatham LN; Steiner M; Liddle PF; Shiah IS; Lam RW; Zis AP; Coote M
Psychopharmacology (Berl); 2000 Sep; 151(4):424-7. PubMed ID: 11026749
[TBL] [Abstract][Full Text] [Related]
18. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
[TBL] [Abstract][Full Text] [Related]
19. New Trends and Current Status of Positron-Emission Tomography and Single-Photon-Emission Computerized Tomography Radioligands for Neuronal Serotonin Receptors and Serotonin Transporter.
Hazari PP; Pandey A; Chaturvedi S; Mishra AK
Bioconjug Chem; 2017 Nov; 28(11):2647-2672. PubMed ID: 28767225
[TBL] [Abstract][Full Text] [Related]
20. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
